Human papillomavirus isolated from transplant-associated porokeratoses of mibelli responsive to topical 5% imiquimod cream.
Esser
Adam C
AC
Department of Dermatology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.
Pittelkow
Mark R
MR
Randle
Henry W
HW
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000627:therapeutic use; D000287:Administration, Topical; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage* / Q000627:therapeutic use; D001706:Biopsy; D004279:DNA, Viral / Q000032:analysis; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D027383:Papillomaviridae / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D016133:Polymerase Chain Reaction; D017499:Porokeratosis / Q000188:drug therapy* / Q000473:pathology / Q000821:virology
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D004279:DNA, Viral; D009824:Ointments; D000077271:Imiquimod